Zepbound NewsLatest News On Zepbound Eli Lilly Shares Surge to Highest Level Since October on Strong Earnings2/6/2025 4:35 PM Eli Lilly Posts Solid Q4 Earnings Fueled by Diabetes and Obesity Drug Sales2/6/2025 10:24 AM Lilly's Diabetes and Obesity Drugs Drive Strong Quarterly Profits2/6/2025 10:23 AM Eli Lilly Stock: A Look Beyond the GLP-1 Boom1/29/2025 11:08 AM Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval1/28/2025 5:12 PM Eli Lilly Cuts 2024 Revenue Guidance as Demand for Weight Loss and Diabetes Drugs Slows1/14/2025 2:46 PM Eli Lilly Cuts 2024 Revenue Forecast Amid Lower-Than-Expected Demand for Obesity and Diabetes Drugs1/14/2025 10:17 AM Eli Lilly Cuts 2024 Revenue Forecast Amid Softer Demand for Weight Loss and Diabetes Drugs1/14/2025 9:48 AM Medicare to Cover Eli Lilly's Obesity Drug Zepbound for Sleep Apnea1/8/2025 2:35 PM Medicare Now Covers Eli Lilly's Obesity Drug Zepbound for Sleep Apnea1/8/2025 2:33 PM Medicare to Cover Obesity Drug Zepbound for Sleep Apnea1/8/2025 2:32 PM Eli Lilly's Zepbound Anti-Obesity Drug Poised to Drive Healthcare Costs1/1/2025 1:31 PM FDA approves Eli Lilly's Zepbound for sleep apnea treatment12/31/2024 1:17 PM Weight Loss Drug Zepbound Approved to Treat Sleep Apnea12/30/2024 2:46 PM Weight Loss Drug Zepbound Approved for Treating Obstructive Sleep Apnea12/24/2024 10:13 PM Tirzepatide No Longer in Short Supply, Impacting Access to Cheaper Alternatives12/24/2024 6:30 AM Zepbound Injection Shows Promise in Treating Obstructive Sleep Apnea (OSA)12/23/2024 6:04 PM Eli Lilly Soars on Obesity Drug Success12/23/2024 10:56 AM FDA Approves Weight Loss Drug Zepbound for Sleep Apnea12/23/2024 4:41 AM FDA Approves First Drug for Obstructive Sleep Apnea12/23/2024 4:31 AM
